Protein A Resin Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast To 2020 - 2027
![]() |
Protein A Resin is an attachment chromatography form of media designed to facilitate one-step cleansing of immunoglobulin classes and parts from biological liquids and cell culture media. It can also be used to suppress the immune response to antigens and proteins. The recombinant protein A ligand is mixed with 4% agarose. The pairing is optimised to provide a high binding capacity for immunoglobulins. The protein A resin's fixed bind capacity is much greater than 20 mg human IgG / ml of established resin. The vibrant binding ability will vary depending on a number of factors, including flow rates and target antibodies.
Over the forecast period, the approval of monoclonal antibodies for the treatment of various diseases is expected to drive growth in the global protein A resin market. For example, in December 2019, the World Health Organization (WHO) prequalified trastuzumab, a monoclonal antibody for the treatment of early stage breast cancer. Trastuzumab costs around $20,000 on average. Trastuzumab biosimilars, on the other hand, are typically 65 percent less expensive than the original.
Furthermore, the emergence of chronic diseases is expected to contribute to the growth of the global protein A resin market. According to the American Cancer Society, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 cancer deaths in the United States in 2019.
Market Segmentation:
By Product
- Natural Protein A
- Recombinant Protein A
By Matrix Type
- Agarose-based
- Glass or Silica Based
- Organic Polymer Based
By Application
- Immunoprecipitation (IP)
- Antibody Purification
By End User
- Biopharmaceutical Manufacturers
- Clinical Research Laboratories
- Academic Institutes
Comments
Post a Comment